Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02977780
Title INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

gliosarcoma

glioblastoma

Therapies

CC-115

Abemaciclib + Temozolomide

Temozolomide

Neratinib + Temozolomide

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST